This report should not be construed as providing investment advice. It is for educational purposes only.  Before making any investment decision, you should always do your own research or consult a investment professional. Estimates Estimates Estimates Power calculations see Aden
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Q1 2025 <-Estimates
See my website on stocks or see my blog at the following sites.  https://spbrunner.com/stocks.html https://spbrunner.blogspot.com/ 3/31/25 <-Estimates
Well Health Technologies Corp TSX WELL OTCQX WHTCF https://well.company/ Fiscal Yr: Dec 31
Year 10/30/13 10/30/14 10/30/15 10/30/16 10/30/17 12/31/18 12/31/19 12/31/20 12/31/21 12/31/22 12/31/23 12/31/24 12/31/25 12/31/26 12/31/27 12/31/28 Description #Y Item Total G
IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS
Cost of Sales $7.4 $21.8 $29.0 $148.6 $265.8 $403.8 $556.7 $781.3 $809.8 <-12 mths 3.64% 10424.42% <-Total Growth 7 Cost of Sales
Change 193.93% 33.01% 412.08% 78.86% 51.89% 37.86% 40.36% 3.64% <-12 mths -90.98% 22.25% <-Median-> 6 Change
Ratio 0.70 0.67 0.58 0.49 0.47 0.52 0.61 0.56 0.55 <-12 mths -1.57% 0.57 <-Median-> 7 Ratio
General & Admin & Finance Chg $4.8 $12.0 $24.3 $111.5 $224.9 $284.4 $343.8 $467.6 $505.9 <-12 mths 8.20% 9655.71% <-Total Growth 7 General & Admin
Change 150.05% 102.87% 358.63% 101.71% 26.46% 20.88% 35.99% 8.20% <-12 mths -77.23% -185.80% <-Median-> 6 Change
Ratio 0.45 0.37 0.48 0.37 0.40 0.37 0.37 0.33 0.34 <-12 mths 2.76% 0.37 <-Median-> 7 Ratio
Total $12.2 $33.8 $53.3 $260.1 $490.8 $688.2 $900.5 $1,248.9 $1,315.6 <-12 mths 5.34% 10122.85% <-Total Growth 7 Total
Change 176.71% 57.77% 387.72% 88.66% 40.23% 30.85% 38.69% 5.34% <-12 mths -86.19% -49.32% <-Median-> 6 Change
Ratio 1.16 1.03 1.06 0.86 0.86 0.89 0.98 0.89 0.89 <-12 mths 0.05% 0.94 <-Median-> 7 Ratio
$1,474 <-12 mths 5.29% Estimates last 12 months from Qtr.
Revenue* $10.6 $32.8 $50.2 $302.3 $569.1 $776.1 $919.7 $1,400.2 $1,590.0 $1,703.0 $1,789.0 13159.52% <-Total Growth 7 Revenue
Increase 0.00% 210.71% 53.12% 501.76% 88.25% 36.36% 18.51% 52.25% 13.56% 13.56% 7.11% 101.01% <-IRR #YR-> 7 Revenue
5 year Running Average $193.0 $346 $523.5 $793.5 $1,051.0 $1,051.0 $1,277.8 94.55% <-IRR #YR-> 5 Revenue
Revenue per Share $0.13 $0.28 $0.31 $1.45 $2.46 $3.21 $3.69 $5.51 $6.26 $6.26 $6.71 60.19% <-IRR #YR-> 3 5 yr Running Average
Increase 121.92% 8.57% 368.98% 70.41% 30.49% 14.86% 49.31% 13.56% 13.56% 7.11% 60.19% <-IRR #YR-> 3 5 yr Running Average
5 year Running Average $0.93 $1.54 $2.22 $3.27 $4.23 $5.48 $6.33 71.19% <-IRR #YR-> 7 Revenue per Share
P/S (Price/Sales) Med 3.83 3.95 15.62 2.46 1.59 1.33 1.43 0.99 0.69 0.69 0.00 78.03% <-IRR #YR-> 5 Revenue per Share
P/S (Price/Sales) Close 3.52 5.49 26.12 3.40 1.15 1.20 1.86 0.72 0.65 0.65 0.60 52.23% <-IRR #YR-> 3 5 yr Running Average
P/S 10 Year Median  1.43 52.23% <-IRR #YR-> 3 5 yr Running Average
*Revenue in M CDN $  P/S Med 20 yr  2.02 15 yr  2.02 10 yr  2.02 5 yr  1.43 -68.11% Diff M/C
Operating Costs to Rev
-$10.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $1,400.2
-$50.2 $0.0 $0.0 $0.0 $0.0 $1,400.2
-$193.0 $0.0 $0.0 $793.5
-$193.0 $0.0 $0.0 $793.5
-$0.13 $0.0 $0.0 $0.0 $0.0 $0.0 $0.00 $5.51
-$0.31 $0.0 $0.0 $0.0 $0.00 $5.51
Amount $134.5 <-12 mths 6.36% Estimates Last 12 months from Qtr
Per Share $0.53 <-12 mths 8.16% Estimates Last 12 months from Qtr
Payout Ratio Adj EPS 0.00% 0.00% Estimates Payout Ratio EPS
Adjusted Net Income CDN$ -$2.8 -$7.8 -$1.3 $16.0 $53.7 $52.4 $8.0 $126.5 4600.29% <-Total Growth 7 Adjusted Profit CDN$
Return on Equity ROE -27.70% -24.46% -0.62% 2.26% 7.33% 6.83% 0.92% 14.64% 1.59% <-Median-> 8 Return on Equity ROE
5Yr Median -27.70% -26.08% -24.46% -12.54% -0.62% 2.26% 2.26% 6.83% -6.58% <-Median-> 8 5 Yr Median
Basic -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 $0.50 1350.00% <-Total Growth 7 AEPS
AEPS* Dilued -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 $0.49 $0.24 $0.21 $0.27 1325.00% <-Total Growth 7 AEPS
Increase -100.00% 87.50% 900.00% 200.00% -8.33% -86.36% 1533.33% -51.02% -12.50% 28.57% 5 3 8 Years of Data, EPS P or N
5 year Running Average $0.04 $0.09 $0.11 $0.21 $0.24 $0.24 $0.25 #NUM! <-IRR #YR-> 7 AEPS
AEPS Yield -8.89% -5.13% -0.12% 1.63% 8.45% 5.71% 0.44% 12.28% 5.94% 5.20% 6.68% #NUM! <-IRR #YR-> 5 AEPS
Payout Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 77.36% <-IRR #YR-> 3 5 yr Running Average
5 year Running Average 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 77.36% <-IRR #YR-> 3 5 yr Running Average
Price/AEPS Median -12.25 -14.03 -481.50 44.38 16.33 19.50 176.33 11.15 18.10 0.00 0.00 13.74 <-Median-> 8 Price/AEPS Median
Price/AEPS High -18.25 -23.13 -841.00 27.88 21.71 26.14 235.00 14.82 21.04 0.00 0.00 18.26 <-Median-> 8 Price/AEPS High
Price/AEPS Low -6.25 -4.94 -122.00 60.88 10.96 12.86 117.67 7.49 15.17 0.00 0.00 9.22 <-Median-> 8 Price/AEPS Low
Price/AEPS Close -11.25 -19.50 -805.00 61.38 11.83 17.50 228.67 8.14 16.83 19.24 14.96 9.99 <-Median-> 8 Price/AEPS Close
Trailing P/AEPS Close -39.00 -100.63 -491.00 35.50 16.04 31.18 133.00 8.24 16.83 19.24 16.04 <-Median-> 7 Trailing P/AEPS Close
Median Values DPR 10 Yrs 0.00% 5 Yrs   0.00% P/AEPS 5 Yrs   in order 19.50 26.14 12.86 17.50 -13.68% Diff M/C DPR 75% to 95% best
$0.11 <-12 mths 466.67% Estimates Last 12 months from Qtr
Difference Basic and Diluted 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.62% 0.00% 0.00% <-Median-> 8 Difference Basic and Diluted
EPS Basic -$0.04 -$0.08 -$0.03 -$0.23 $0.01 $0.00 $0.13 -$0.03 25.00% <-Total Growth 7 EPS Basic
EPS Diluted* -$0.04 -$0.08 -$0.03 -$0.23 $0.01 $0.00 $0.13 -$0.03 -$0.13 -$0.01 25.00% <-Total Growth 7 EPS Diluted
Increase -100.00% 62.50% -666.67% 102.70% -94.41% 37400.71% -123.08% -322.33% 95.68% 3 5 8 Years of Data, EPS P or N
Earnings Yield -8.89% -5.13% -0.37% -4.68% 0.22% 0.01% 1.90% -0.75% -3.14% -0.14% -4.03% <-IRR #YR-> 7 Earnings per Share
5 year Running Average -$0.07 -$0.07 -$0.02 -$0.02 $0.00 -$0.01 0.00% <-IRR #YR-> 5 Earnings per Share
10 year Running Average -$0.03 -$0.04 -$0.04 -30.88% <-IRR #YR-> 3 5 yr Running Average
* Diluted ESP per share  E/P 10 Yrs -0.56% 5Yrs 0.01% -30.88% <-IRR #YR-> 3 5 yr Running Average
$0.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.03
$0.03 $0.00 $0.00 $0.00 $0.00 -$0.03
$0.07 $0.00 $0.00 -$0.02
$0.07 $0.00 $0.00 -$0.02
Dividend* $0.00 Estimates Dividend*
Increase 0.00% Estimates Increase
Payout Ratio EPS 0.00% Estimates Payout Ratio EPS
Special Dividends $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-Median-> 7 Special Dividends
Dividend* $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 6 Dividends
Increase 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 6 Years of data, Count P, N
Average Increases 5 Year Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 7 5 year Increases
Dividends 5 Yr Running $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 6 Dividends 5 Yr Running
Yield H/L Price 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 7 Yield H/L Price
Yield on High  Price 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 7 Yield on High  Price
Yield on Low Price 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 7 Yield on Low Price
Yield on Close Price 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 7 Yield on Close Price
Payout Ratio EPS N/C N/C N/C 0.00% 0.00% 0.00% N/C 0.00% 0.00% 0.00% $0.00 <-Median-> 3 DPR EPS
DPR EPS 5 Yr Running #DIV/0! #DIV/0! #DIV/0! N/C N/C N/C N/C 0.00% 0.00% 0.00% #DIV/0! <-Median-> 0 DPR EPS 5 Yr Running
Payout Ratio CFPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 7 DPR CF
DPR CF 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 7 DPR CF 5 Yr Running
Payout Ratio CFPS WC 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 7 DPR CF WC
DPR CF WC 5 Yr Running 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% #VALUE! 0.00% $0.00 <-Median-> 7 DPR CF WC 5 Yr Running
Median Values 10 Yr Med 10 Yr Cl 0.00% 0.00% 5 Yr Med 5 Yr Cl 0.00% 0.00% 5 Yr Med Payout 0.00% 0.00% 0.00% 0.00% <-IRR #YR-> 5 Dividends
* Dividends per share  10 Yr Med and Cur. #DIV/0! #DIV/0! 5 Yr Med and Cur. #DIV/0! #DIV/0! Last Div Inc ---> $0.00 $0.00 #DIV/0! 0.00% <-IRR #YR-> 10 Dividends
Dividends Growth 15 0.00% <-IRR #YR-> 15 Dividends
Dividends Growth 5 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 5
Dividends Growth 10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 10
Dividends Growth 15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 Dividends Growth 15
Historical Dividends Historical High Div #NUM! Low Div #NUM! 10 Yr High #NUM! 10 Yr Low #NUM! Med Div 0.00% Close Div 0.00% Historical Dividends
High/Ave/Median Values Curr diff #NUM! #NUM! #NUM! #NUM! #NUM! #NUM! Exp. #DIV/0! Exp. #DIV/0! High/Ave/Median 
Adjusted Historical Dividends Historical High Div #NUM! Low Div #NUM! 10 Yr High #NUM! 10 Yr Low #NUM! Med Div 0.00% Close Div 0.00% Adjusted Historical Dividends
High/Ave/Median Values Curr diff #NUM! #NUM! #NUM! #NUM! #NUM! #NUM! Exp. #DIV/0! Exp. #DIV/0! High/Ave/Median 
Future Dividend Yield Div Yield $0.00 earning in 5 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield
Future Dividend Yield Div Yield 0.00% earning in 10 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield
Future Dividend Yield Div Yield 0.00% earning in 15 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Yield
Future Dividend Paid Div Paid $0.00 earning in 5 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid
Future Dividend Paid Div Paid $0.00 earning in 10 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid
Future Dividend Paid Div Paid $0.00 earning in 15 Years at IRR of 0.00% Div Inc. #DIV/0! Future Dividend Paid
Dividend Covering Cost Total Div $0.00 over 5 Years at IRR of 0.00% Div Cov. 0.00% Dividend Covering Cost
Dividend Covering Cost Total Div $0.00 over 10 Years at IRR of 0.00% Div Cov. 0.00% Dividend Covering Cost
Dividend Covering Cost Total Div $0.00 over 15 Years at IRR of 0.00% Div Cov. 0.00% Dividend Covering Cost
Yield if held 5 years 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 3 Paid Median Price
Yield if held 10 years 0.00% #NUM! <-Median-> 0 Paid Median Price
Yield if held 15 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price
year 35 BMO, EMP, T, JNJ
Cost covered if held 5 years 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 3 Paid Median Price
Cost covered if held 10 years 0.00% #NUM! <-Median-> 0 Paid Median Price
Cost covered if held 15 years #DIV/0! #NUM! <-Median-> 0 Paid Median Price
Yr  Item
Revenue Growth  $50.2 $302.3 $569.1 $776.1 $919.7 $1,400.2 $1,474 <-12 mths 5.29% 2686.97% <-Total Growth 5 Revenue Growth 
AEPS Growth -$0.01 $0.08 $0.24 $0.22 $0.03 $0.49 $0.53 <-12 mths 8.16% 5000.00% <-Total Growth 5 AEPS Growth
Net Income Growth -$3.7 -$43.8 $1.4 $0.1 $32.6 -$7.4 $27 <-12 mths 464.55% -99.65% <-Total Growth 5 Net Income Growth
Cash Flow Growth -$5.4 $22.3 $76.5 $66.4 $9.5 $121.9 $116 <-12 mths -5.23% 2364.67% <-Total Growth 5 Cash Flow Growth
Dividend Growth $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-12 mths #DIV/0! 0.00% <-Total Growth 5 Dividend Growth
Stock Price Growth $8.05 $4.91 $2.84 $3.85 $6.86 $3.99 $4.04 <-12 mths 1.25% -50.43% <-Total Growth 5 Stock Price Growth
Revenue Growth  $10.6 $32.8 $50.2 $302.3 $569.1 $776.1 $919.7 $1,400.2 $1,590 <-this year 13.56% 13159.52% <-Total Growth 7 Revenue Growth 
AEPS Growth -$0.04 -$0.08 -$0.01 $0.08 $0.24 $0.22 $0.03 $0.49 $0.24 <-this year -51.02% 1325.00% <-Total Growth 7 AEPS Growth
Net Income Growth -$2.8 -$7.8 -$3.7 -$43.8 $1.4 $0.1 $32.6 -$7.4 -$31 <-this year -323.51% -161.93% <-Total Growth 7 Net Income Growth
Cash Flow Growth -$1.1 -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 $121.9 $116 <-this year -5.23% 11635.74% <-Total Growth 7 Cash Flow Growth
Dividend Growth $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 <-this year #DIV/0! #DIV/0! <-Total Growth 7 Dividend Growth
Stock Price Growth $0.44 $0.45 $1.56 $8.05 $4.91 $2.84 $3.85 $6.86 $3.99 $4.04 <-this year 1.25% 797.78% <-Total Growth 9 Stock Price Growth
Dividends on Shares $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 No of Years 8 Total Dividends
Share Value $1,000.12 $1,022.85 $3,545.88 $18,297.65 $11,160.43 $6,455.32 $8,751.05 $15,592.78 $9,069.27 $9,182.92 $9,182.92 $9,182.92 $9,069.27 No of Years 8 Share Value
Total -$1,000.12 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $9,069.27 31.73% <-IRR $9,069.27 Total Return
Graham Number AEPS $2.47 $4.14 $3.97 $1.53 $6.12 $4.30 $4.02 $4.56 148.01% <-Total Growth 4 Graham Number AEPS
Increase 67.60% -4.11% -61.35% 299.29% -29.84% -6.46% 13.39% 31.74% <-Median-> 4 Increase
Price/GP Ratio Med 1.44 0.95 1.08 3.45 0.89 1.01 1.08 <-Median-> 5 Price/GP Ratio Med
Price/GP Ratio High 0.90 1.26 1.45 4.60 1.19 1.18 1.26 <-Median-> 5 Price/GP Ratio High
Price/GP Ratio Low 1.97 0.64 0.71 2.30 0.60 0.85 0.71 <-Median-> 5 Price/GP Ratio Low
Price/GP Ratio Close 1.99 0.69 0.97 4.47 0.65 0.94 1.01 0.89 0.97 <-Median-> 5 Price/GP Ratio Close
Prem/Disc Close 98.90% -31.35% -2.96% 347.39% -34.83% -5.94% 0.55% -11.32% -2.96% <-Median-> 5 Graham Price
Graham Number EPS $0.67 $0.16 $3.19 $3.15 #NUM! #NUM! $0.00 374.12% <-Total Growth 3 Graham Number EPS
Increase 1926.79% -1.20% #NUM! #NUM! #NUM! 962.79% <-Median-> 2 Increase
Price/GP Ratio Med 5.89 27.24 1.66 1.73 3.81 <-Median-> 4 Price/GP Ratio Med
Price/GP Ratio High 7.83 36.51 2.21 2.30 5.07 <-Median-> 4 Price/GP Ratio High
Price/GP Ratio Low 3.95 17.97 1.11 1.16 2.56 <-Median-> 4 Price/GP Ratio Low
Price/GP Ratio Close 4.27 24.45 2.15 1.27 #NUM! #NUM! #DIV/0! 3.21 <-Median-> 4 Price/GP Ratio Close
Prem/Disc Close 326.98% 2344.70% 114.92% 26.53% #NUM! #NUM! #DIV/0! 220.95% <-Median-> 4 Graham Price
Based on EPS 3 Yrs EPS $1.87 $1.60 #NUM! #NUM! #DIV/0! <-Total Growth 0 Based on EPS 3 Yrs EPS
Increase -14.06% #NUM! #NUM! #NUM! <-Median-> 0 Increase
Price/GP Ratio Med 2.93 292.88% <-Median-> 1 Price/GP Ratio Med
Price/GP Ratio High 3.89 3.89 <-Median-> 1 Price/GP Ratio High
Price/GP Ratio Low 1.97 1.97 <-Median-> 1 Price/GP Ratio Low
Price/GP Ratio Close 2.14 2.52 #NUM! #NUM! 2.14 <-Median-> 1 Price/GP Ratio Close
Prem/Disc Close 113.83% 151.94% #NUM! #NUM! 1.14 <-Median-> 1 Graham Price
Month, Year Dec-13 Dec-14 Dec-15 Dec-16 Dec-17 Dec-18 Dec-19 Dec-20 Dec-21 Dec-22 Dec-23 Dec-24 Dec-25 Dec-26 Dec-27 Dec-28 7.00 <Count Years> 8 Month, Year
Price Close $0.44 $0.45 $1.56 $8.05 $4.91 $2.84 $3.85 $6.86 $3.99 $4.04 $4.04 $4.04 806.82% <-Total Growth 8 Stock Price
Increase 2.27% 246.67% 416.03% -39.01% -42.16% 35.56% 78.18% -41.84% 1.25% 0.00% 0.00% -120.50 <-Median-> 8 CAPE (10 Yr P/E)
P/E Ratio -11.25 -19.50 -268.33 -21.35 457.83 11105.98 52.77 -133.00 -31.89 -738.57 #DIV/0! -13.10% <-IRR #YR-> 5 Stock Price
Trailing P/E Ratio -39.00 -100.63 -163.67 -12.35 620.64 19788.84 30.69 -134.67 -31.89 -738.57 31.73% <-IRR #YR-> 8 Stock Price
CAPE (10 Yr P/E) -120.50 -92.44 -100.07 #DIV/0! -13.10% <-IRR #YR-> 5 Price & Dividend
Median 10, 5 Yrs D.  per yr 0.00% 0.00% % Tot Ret 0.00% 0.00% T P/E -$12.35 $30.69 P/E:  -$15.38 $52.77 107.39% Diff M/C 31.73% <-IRR #YR-> 8 Price & Dividend
Price 15 D.  per yr #NUM! % Tot Ret #NUM! CAPE Diff -73.54% #NUM! <-IRR #YR-> 15 Stock Price
Price & Dividend 15 #NUM! <-IRR #YR-> 15 Price & Dividend
Price  5 -$8.05 $0.00 $0.00 $0.00 $0.00 $3.99 Price  5
Price 10 -$0.44 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.99 Price 10
Price & Dividend 5 -$8.05 $0.00 $0.00 $0.00 $0.00 $3.99 Price & Dividend 5
Price & Dividend 10 -$0.44 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.99 Price & Dividend 10
Price  15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.99 Price  15
Price & Dividend 15 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.99 Price & Dividend 15
Price H/L Median $0.49 $1.12 $4.82 $3.55 $3.92 $4.29 $5.29 $5.47 $4.35 1015.31% <-Total Growth 7 Stock Price
Increase 129.08% 328.95% -26.27% 10.42% 9.44% 23.31% 3.31% -20.49% 2.56% <-IRR #YR-> 5 Stock Price
P/E Ratio -12.25 -14.03 -160.50 -15.43 631.93 0.00 40.69 -182.17 -34.29 41.13% <-IRR #YR-> 7 Stock Price
Trailing P/E Ratio -28.06 -60.19 -118.33 -17.04 691.58 0.00 0.00 -144.83 2.56% <-IRR #YR-> 5 Price & Dividend
P/E on Running 5 yr Average -214.26 -221.34 -1078.16 41.13% <-IRR #YR-> 7 Price & Dividend
P/E on Running 10 yr Average -199.85 -108.58 -13.14 P/E Ratio Historical Median
Median 10, 5 Yrs D.  per yr 0.00% 0.00% % Tot Ret 0.00% 0.00% T P/E -17.04 0.00 P/E:  -13.14 0.00 Count 7 Years of data
-$4.82 $0.00 $0.00 $0.00 $0.00 $5.47
-$0.49 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.47
-$4.82 $0.00 $0.00 $0.00 $0.00 $5.47
-$0.49 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.47
High Months May Aug Oct Feb Apr May Dec Jan Jun
Price High $0.73 $1.85 $8.41 $2.23 $5.21 $5.75 $7.05 $7.26 $5.05 894.52% <-Total Growth 7 Stock Price
Increase 153.42% 354.59% -73.48% 133.63% 10.36% 22.61% 2.98% -30.44% -2.90% <-IRR #YR-> 5 Stock Price
P/E Ratio -18.25 -23.13 -280.33 -9.70 0.00 0.00 54.23 -242.00 -39.86 38.84% <-IRR #YR-> 7 Stock Price
Trailing P/E Ratio -46.25 -105.13 -74.33 -22.65 0.00 0.00 55.85 -168.33 -13.97 P/E Ratio Historical Median
Median 10, 5 Yrs T P/E -22.65 0.00 P/E:  -13.97 0.00 #NUM! P/E Ratio Historical High
-$8.41 $0.00 $0.00 $0.00 $0.00 $7.26
-$0.73 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $7.26
Low Months Mar Jan Mar Dec Dec Jan Apr Dec Mar
Price Low $0.25 $0.40 $1.22 $4.87 $2.63 $2.83 $3.53 $3.67 $3.64 1368.00% <-Total Growth 7 Stock Price
Increase 58.00% 208.86% 299.18% -46.00% 7.60% 24.73% 3.97% -0.82% 24.64% <-IRR #YR-> 5 Stock Price
P/E Ratio -6.25 -4.94 -40.67 -21.17 0.00 0.00 27.15 -122.33 -28.73 46.78% <-IRR #YR-> 7 Stock Price
Trailing P/E Ratio -9.88 -15.25 -162.33 -11.43 0.00 0.00 0.00 -121.33 -5.59 P/E Ratio Historical Median
Median 10, 5 Yrs T P/E T P/E -9.88 0.00 P/E:  -5.59 0.00 #NUM! P/E Ratio Historical Low
-$0.25 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.67
Free Cash Flow Mkt Sc -$6.52 $19.59 $70.14 $58.33 -$6.70 $94.02 $87.86 $131.20
Change -36.36% 686.29% 133.82% -10.06% -126.62% 823.27% -29.50%
$101 <-12 mths -18.61%
Free Cash Flow MS -$1.22 -$3.85 -$5.25 $30.78 $71.97 $64.73 -$17.23 $124.62 $87.86 $131.20 10314.75% <-Total Growth 7 Free Cash Flow
Change -215.57% 686.29% 133.82% -10.06% -126.62% 823.27% -29.50% 49.33% #NUM! <-IRR #YR-> 5 Free Cash Flow MS
FCF/CF from Op Ratio 1.15 1.46 0.98 1.38 0.94 0.97 -1.81 1.02 0.76 #VALUE! #NUM! <-IRR #YR-> 7 Free Cash Flow MS
Free Cash Flow Yield -3.28% -2.14% -0.40% 3.00% 10.97% 6.96% -1.01% 12.30% 8.56% 12.79% 1.30% <-Median-> 8 Free Cash Flow Yield
Dividends paid $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 7 Dividends paid
Percentage paid 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% $0.00 <-Median-> 8 Percentage paid
5 Year Coverage 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5 Year Coverage
Dividend Coverage Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 <-Median-> 8 Dividend Coverage Ratio
5 Year of Coverage 0.00 0.00 0.00 0.00 0.00 0.00 5 Year of Coverage
-$12 <-12 mths -14.86%
Free Cash Flow WSJ -$7.18 -$30.21 $65.70 $37.20 -$10.55 $87.92 $87.86 $131.20 1325.17% <-Total Growth 5 Free Cash Flow
Change -320.94% 317.49% -43.37% -128.37% 933.03% -0.07% 49.33% #NUM! <-IRR #YR-> 5 Free Cash Flow MS
FCF/CF from Op Ratio 1.33 -1.36 0.86 0.56 -1.11 0.72 0.76 #VALUE! #NUM! <-IRR #YR-> 5 Free Cash Flow MS
Free Cash Flow Yield -0.55% -2.94% 10.01% 4.00% -0.62% 8.68% 8.56% 12.79% 1.73% <-Median-> 6 Free Cash Flow Yield
Dividends paid $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 #DIV/0! <-Total Growth 5 Dividends paid
Percentage paid 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% $0.00 <-Median-> 6 Percentage paid
5 Year Coverage 0.00% 0.00% 0.00% 0.00% 5 Year Coverage
Dividend Coverage Ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 <-Median-> 6 Dividend Coverage Ratio
5 Year of Coverage 0.00 0.00 0.00 0.00 5 Year of Coverage
Market Cap in $M $18.0 $37.1 $180.3 $1,312.1 $1,026.9 $656.2 $929.5 $1,708.8 $1,013.4 $1,026.1 $1,026.1 $1,026.1 5515.56% <-Total Growth 8 Market Cap
Diluted # of Shares in Millions 23.18 71.42 91.96 133.91 190.90 220.69 236.54 254.65 252.80 250.49 250.49 250.49 990.66% <-Total Growth 8 Diluted # of Shares in Million
Change 208.14% 28.75% 45.62% 42.56% 15.61% 7.18% 7.66% -0.73% -0.91% 0.00% 0.00% 34.81% <-IRR #YR-> 8 Change
Difference Diluted/Basic 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.1% 0.0% 0.0% 0.0% 0.0% 13.55% <-IRR #YR-> 5 Difference Diluted/Basic
Change in Diluted Shares per Year
-23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.8
-133.9 0.0 0.0 0.0 0.0 252.8
Basic # of Shares in Millions 23.18 71.42 91.96 133.91 190.90 220.69 236.54 246.76 252.80 250.49 250.49 250.49 990.66% <-Total Growth 8 Basic
Change 208.14% 28.75% 45.62% 42.56% 15.61% 7.18% 4.32% 2.45% -0.91% 0.00% 0.00% 22.18% <-Median-> 8 Change
Difference Basic/Outstanding 76.95% 15.57% 25.68% 21.72% 9.56% 4.69% 2.07% 0.94% 0.47% 1.40% 1.40% 1.40% 9.56% <-Median-> 9 Difference Basic/Outstanding
$115.5 <-12 mths -5.23% Estimates last 12 months from Qtr.
# of Share in Millions 41.014 82.546 115.571 162.999 209.147 231.047 241.428 249.092 253.986 253.986 253.986 253.986 25.60% <-IRR #YR-> 8 Shares
Change 101.26% 40.01% 41.04% 28.31% 10.47% 4.49% 3.17% 1.96% 0.00% 0.00% 0.00% 9.28% <-IRR #YR-> 5 Shares
Cash Flow from Operations $M -$0.643 -$1.057 -$2.633 -$5.382 $22.268 $76.546 $66.437 $9.522 $121.888 $115.5 <-12 mths #DIV/0! <-Total Growth 8 Cash Flow
Increase -64.23% -149.17% -104.43% 513.74% 243.75% -13.21% -85.67% 1180.07% -5.23% <-12 mths Stock Options
5 year Running Average $2.5 $17.9 $31.4 $33.9 $59.3 $78.0 <-12 mths 2263.25% <-Total Growth 4 CF 5 Yr Running
CFPS -$0.02 -$0.01 -$0.02 -$0.03 $0.11 $0.33 $0.28 $0.04 $0.48 $0.45 <-12 mths 3159.41% <-Total Growth 8 Cash Flow per Share
Increase 18.40% -77.97% -44.95% 422.45% 211.17% -16.94% -86.11% 1155.40% -5.23% <-12 mths #NUM! <-IRR #YR-> 8 Cash Flow
5 year Running Average $0.00 $0.07 $0.13 $0.14 $0.25 $0.32 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow
P/CF on Med Price 0.00 -38.28 -49.27 -145.82 33.34 11.83 15.59 138.38 11.39 9.55 <-12 mths #NUM! <-IRR #YR-> 8 Cash Flow per Share
P/CF on Closing Price -28.05 -35.16 -68.48 -243.80 46.12 8.57 13.99 179.46 8.31 8.88 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow per Share
-21.99% Diff M/C 172.94% <-IRR #YR-> 4 CFPS 5 yr Running
$173.98 <-12 mths 9.71%
Excl.Working Capital CF $0.0 -$0.5 -$0.3 $1.9 $11.2 $6.1 $10.2 -$6.7 $36.7 $0.0 $0.0 172.94% <-IRR #YR-> 4 CFPS 5 yr Running
Cash Flow from Operations $M WC -$0.6 -$1.6 -$3.0 -$3.5 $33.5 $82.6 $76.7 $2.9 $158.6 $115.5 <-12 mths 26383.29% <-Total Growth 8 Cash Flow less WC
Increase -158.30% -89.56% -17.15% 1066.87% 146.84% -7.16% -96.28% 5464.60% -27.17% <-12 mths #NUM! <-IRR #YR-> 8 Cash Flow less WC
5 year Running Average $5.0 $21.6 $37.3 $38.4 $70.8 $87.2 <-12 mths #NUM! <-IRR #YR-> 5 Cash Flow less WC
CFPS Excl. WC -$0.01 -$0.02 -$0.03 -$0.02 $0.16 $0.36 $0.32 $0.01 $0.62 $0.45 <-12 mths 94.23% <-IRR #YR-> 4 CF less WC 5 Yr Run
Increase -28.34% -35.39% 16.94% 853.53% 123.45% -11.16% -96.40% 5357.38% -27.17% <-12 mths 94.23% <-IRR #YR-> 4 CF less WC 5 Yr Run
5 year Running Average $0.02 $0.09 $0.16 $0.17 $0.29 $0.35 <-12 mths #NUM! <-IRR #YR-> 8 CFPS - Less WC
P/CF on Median Price 0.00 -25.95 -43.91 -226.76 22.19 10.96 13.51 462.35 8.75 9.55 <-12 mths #NUM! <-IRR #YR-> 5 CFPS - Less WC
P/CF on Closing Price -29.91 -23.83 -61.02 -379.12 30.69 7.94 12.12 599.57 6.39 8.88 <-12 mths 107.33% <-IRR #YR-> 4 CFPS 5 yr Running
*Operational Cash Flow. CF/-WC P/CF Med 10 yr 11.39 5 yr  15.59 P/CF Med 10 yr 8.75 5 yr  13.51 1.50% Diff M/C 107.33% <-IRR #YR-> 4 CFPS 5 yr Running
$0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.48 Cash Flow per Share
$0.03 $0.00 $0.00 $0.00 $0.00 $0.48 Cash Flow per Share
$0.00 $0.00 $0.00 $0.00 $0.25 CFPS 5 yr Running
$0.00 $0.00 $0.00 $0.00 $0.25 CFPS 5 yr Running
$0.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $158.6 Cash Flow less WC
$3.5 $0.0 $0.0 $0.0 $0.0 $158.6 Cash Flow less WC
-$5.0 $0.0 $0.0 $0.0 $70.8 CF less WC 5 Yr Run
-$5.0 $0.0 $0.0 $0.0 $70.8 CF less WC 5 Yr Run
$0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.62 CFPS - Less WC
$0.02 $0.00 $0.00 $0.00 $0.00 $0.62 CFPS - Less WC
For banks, use Net Income, not CF
OPM Ratio -10.01% -8.02% -10.71% 7.37% 13.45% 8.56% 1.04% 8.71% 7.26% 187.00% <-Total Growth 7 OPM
Increase 19.81% -33.51% 168.76% 82.60% -36.35% -87.91% 740.79% -16.55% Should increase  or be stable.
Diff from Median -338% -291% -355% 75% 220% 104% -75% 107% 73% 0.00 <-Median-> 8 OPM
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 4.20% 5 Yrs 8.56% should be  zero, it is a   check on calculations
$219.17 <-12 mths 7.61%
Adjusted EBITDA to Shareholders $39.79 $149.01
Adjusted EBITDA to NCI $6.88 $54.67
Adjusted EBITDA $0.97 $1.41 -$92.01 $60.36 $104.56 $113.39 $46.67 $203.68 $185.60 $206.50 $231.80 20791.79% <-Total Growth 7 Adjusted EBITDA
Change 44.30% -6640.54% 165.60% 73.22% 8.45% -58.85% 336.48% -8.88% 11.26% 12.25% 44.30% <-Median-> 7 Change
EBITDA Margin 9.23% 4.29% -183.14% 19.97% 18.37% 14.61% 5.07% 14.55% 11.67% 12.13% 12.96% 11.89% <-Median-> 8 EBITDA Margin
$125.39 <-12 mths 14.10%
EBIT -$12.79 $23.31 $35.16 -$30.20 $109.90 $63.66 $81.85 $97.50 <-Total Growth 4 EBIT
Change 282.25% 50.84% -185.89% 463.91% -42.07% 28.57% 19.12% 166.54% <-Median-> 4 Change
EBIT Margin -4.23% 4.10% 4.53% -3.28% 7.85% 4.00% 4.81% 5.45% 4.10% <-Median-> 5 EBITDA Margin
Long Term Debt $0.41 $0.00 $4.70 $0.95 $290.60 $263.00 $298.91 $335.98 $420.65 $483.43 101935.87% <-Total Growth 8 Debt
Change -100.00% 0.00% -79.83% 30555.78% -9.50% 13.66% 12.40% 25.20% 14.92% 6.20% <-Median-> 8 Change
Debt/Market Cap Ratio 0.02 0.00 0.03 0.00 0.28 0.40 0.32 0.20 0.42 0.47 0.20 <-Median-> 9 Debt/Market Cap Ratio
Assets/Current Liabilities Ratio 0.00 5.83 6.98 11.61 9.19 9.66 9.21 4.73 5.87 4.73 6.98 <-Median-> 9 Assets/Current Liab Ratio
Current Liabilities/Asset Ratio 1564.26 0.17 0.14 0.09 0.11 0.10 0.11 0.21 0.17 0.21 0.14 <-Median-> 9 Current Liab/Asset Ratio
Debt to Cash Flow (Years) 0.00 0.00 0.00 0.00 13.05 3.44 4.50 35.28 3.45 4.19 3.44 <-Median-> 9 Debt to Cash Flow (Years)
Intangibles $11.30 $21.23 $405.52 $571.27 $555.20 $573.96 $760.21 $782.94 6627.74% <-Total Growth 6 Intangibles
Goodwill $8.46 $13.58 $110.12 $611.75 $499.29 $508.06 $565.12 $787.62 $819.20 9210.08% <-Total Growth 7 Goodwill
Total $8.46 $24.88 $131.35 $1,017.27 $1,070.56 $1,063.26 $1,139.08 $1,547.83 $1,602.14 #DIV/0! <-Total Growth 7 Total
Change 194.08% 427.94% 674.49% 5.24% -0.68% 7.13% 35.88% 3.51% 35.88% <-Median-> 7 Change
Intangible/Market Cap Ratio 0.23 0.14 0.10 0.99 1.63 1.14 0.67 1.53 1.56 0.83 <-Median-> 8 Intangible/Market Cap Ratio
Current Assets $442.2 $3.7 $18.9 $103.4 $142.9 $150.9 $176.4 $346.1 $369.6 $378.6 -16.42% <-Total Growth 8 Current Assets
Current Liabilities $691.8 $2.2 $8.4 $22.6 $137.3 $136.5 $153.0 $382.1 $357.5 $457.9 -48.32% <-Total Growth 8 Current Liabilities
Liquidity Ratio 0.64 1.71 2.25 4.57 1.04 1.11 1.15 0.91 1.03 0.83 1.11 <-Median-> 9 Ratio
Liq. with CF aft div 0.64 1.23 1.94 4.33 1.20 1.67 1.59 0.93 1.37 1.08 1.37 <-Median-> 5 Liq. with CF aft div
Liq. with CF aft div (WC) 0.64 1.00 1.90 4.41 1.28 1.71 1.65 0.91 1.48 1.08 Liq. with CF aft div (WC)
Liq. CF re  Inv+Div  0.64 0.27 0.85 1.47 0.26 1.30 1.04 0.80 1.10 1.08 1.04 <-Median-> 5 Liq. CF re  Inv+Div 
Curr Long Term Debt $0.299 $0.000 $0.000 $0.753 $45.914 $34.153 $46.108 $9.384 $6.427 $8.989 $34.2 <-Median-> 5 Curr Long Term Debt
Liquidity Less CLTD 0.64 1.71 2.25 4.72 1.56 1.47 1.65 0.93 1.05 0.84 1.47 <-Median-> 5 Liquidity Less CLTD
Liq. with CF aft div 0.64 1.23 1.94 4.48 1.81 2.22 2.27 0.95 1.40 1.10 1.81 <-Median-> 5 Liq. with CF aft div
Banks usually have a ratio of 1.04 or 1.05
Assets $0.4 $12.8 $58.5 $262.7 $1,262.4 $1,319.0 $1,409.3 $1,807.3 $2,096.9 $2,166.0 474069.82% <-Total Growth 8 Assets
Liabilities $1.1 $2.6 $26.5 $43.8 $554.4 $503.8 $563.2 $877.6 $1,057.5 $1,118.7 95686.44% <-Total Growth 8 Liabilities
Debt Ratio 0.40 4.86 2.21 6.00 2.28 2.62 2.50 2.06 1.98 1.94 2.28 <-Median-> 9 Ratio
Estimates BVPS $3.36 $3.55 Estimates Estimates BVPS
Estimate Book Value $853.4 $901.6 Estimates Estimate Book Value
P/B Ratio (Close) 1.20 1.14 Estimates P/B Ratio (Close)
Difference from 10 year median -20.83% Diff M/C Estimates Difference from 10 yr med.
Book Value -$0.7 $10.1 $32.0 $219.0 $708.1 $815.3 $846.1 $929.7 $1,039.4 $1,047.3
NCI 0.00 0.00 $0.0 1.61 0.00 82.91 78.48 62.11 175.89 179.50
Book Value Net -$0.7 $10.1 $32.0 $217.4 $708.1 $732.3 $767.7 $867.6 $863.5 $867.8 $867.8 $867.8 130581.65% <-Total Growth 8 Book Value
Book Value per share -$0.02 $0.12 $0.28 $1.33 $3.39 $3.17 $3.18 $3.48 $3.40 $3.42 $3.42 $3.42 21170.57% <-Total Growth 8 Book Value per Share
Increase 861.74% 125.07% 382.07% 153.86% -6.37% 0.32% 9.54% -2.39% 0.50% 0.00% 0.00% -22.15% P/B Ratio Current/Historical Median
P/B Ratio (Median) 0.00 3.99 4.06 3.61 1.05 1.24 1.35 1.52 1.61 1.27 0.00 0.00 1.52 P/B Ratio Historical Median
P/B Ratio (Close) -27.27 3.66 5.64 6.04 1.45 0.90 1.21 1.97 1.17 1.18 1.18 1.18 #NUM! <-IRR #YR-> 8 Book Value per Share
Change 113.43% 54.03% 7.04% -75.97% -38.22% 35.14% 62.66% -40.41% 0.75% 0.00% 0.00% 20.58% <-IRR #YR-> 5 Book Value per Share
Median 10 year P/B Ratio 0.00 1.99 3.99 3.80 3.61 2.42 1.35 1.43 1.52 1.43 1.43 1.31 1.52 <-Median-> 5 Median 10 year P/B Ratio
Leverage (A/BK) 0.00 1.26 1.83 1.21 1.78 1.80 1.84 2.08 2.43 2.50 1.84 <-Median-> 5 A/BV
Debt/Equity Ratio 0.00 0.26 0.83 0.20 0.78 0.69 0.73 1.01 1.22 1.29 0.78 <-Median-> 5 Debt/Eq Ratio
Shareholders' Equity (Assets less Liabilities) P/B Ratios 10 yr Med 1.52 5 yr Med 1.35 -22.15% Diff M/C 1.80 Historical Leverage (A/BK)
$0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $3.40
-$1.33 $0.00 $0.00 $0.00 $0.00 $3.40
$13.32 <-12 mths 140.16% Estimates last 12 months from Qtr.
Total Comprehensive Income -$5.56 -$2.80 -$7.79 -$3.34 -$24.80 $52.64 $3.07 $71.11 -$21.31
NCI $0.00 $0.00 $0.02 $0.44 $12.85 $17.59 $16.39 -$2.94 $11.86
Shareholders -$5.56 -$2.80 -$7.82 -$3.78 -$37.66 $35.05 -$13.33 $74.05 -$33.18 -496.85% <-Total Growth 8 Comprehensive Income
Increase 49.60% -179.09% 51.67% -896.54% 193.06% -138.02% 655.68% -144.80% -138.02% <-Median-> 5 Comprehensive Income
5 Yr Running Average -$1 -$2 -$3 -$4 -$12 -$3 -$6 $11 $5 25.02% <-IRR #YR-> 8 Comprehensive Income
ROE 0.0% 0.0% 0.0% 0.0% 0.0% 4.8% 0.0% 8.5% 0.0% 54.41% <-IRR #YR-> 5 Comprehensive Income
5Yr Median 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% #NUM! <-IRR #YR-> 8 5 Yr Running Average
% Difference from Net Income 0.0% 0.0% 0.0% 0.0% 0.0% 2459.9% 0.0% 127.07% 0.00% #NUM! <-IRR #YR-> 5 5 Yr Running Average
Median Values Diff 5, 10 yr 0.0% 0.0% 0.0% <-Median-> 5 Return on Equity
$5.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 -$33.2
$3.8 $0.0 $0.0 $0.0 $0.0 -$33.2
$1.1 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $5.0
$4.0 $0.0 $0.0 $0.0 $0.0 $5.0
Current Liability Coverage Ratio 0.00 -0.71 -0.35 -0.15 0.24 0.61 0.50 0.01 0.44 0.25   CFO / Current Liabilities
5 year Median -0.15 -0.15 0.24 0.24 0.44 0.44 0.01 <-Median-> 9 Current Liability Cov Ratio
Asset Efficiency Ratio -136.44% -12.20% -5.05% -1.32% 2.65% 6.26% 5.44% 0.16% 7.56% 5.33% CFO / Total Assets
5 year Median -5.05% -1.32% 2.65% 2.65% 5.44% 5.44% 0.2% <-Median-> 9 Return on Assets 
Return on Assets ROA -1256.91% -22.00% -13.36% -1.40% -3.47% 0.10% 0.01% 1.80% -0.35% -1.44% Net  Income/Assets Return on Assets
5Yr Median -13.36% -3.47% -1.40% 0.01% 0.01% 0.01% -1.4% <-Median-> 9 Asset Efficiency Ratio
Return on Equity ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.19% 0.01% 3.76% 0.00% 0.00% Net Inc/ Shareholders' equity Return on Equity
5Yr Median 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.0% <-Median-> 9 Return on Equity
$27 <-12 mths 464.55% Estimates Last 12 months from Qtr
Net Income -$5.56 -$2.81 -$7.79 -$3.21 -$30.90 $18.68 $16.64 $29.10 $4.46
NCI $0.00 $0.00 $0.02 $0.48 $12.89 $17.31 $16.56 -$3.51 $11.82
Net Income -$5.56 -$2.81 -$7.82 -$3.69 -$43.79 $1.37 $0.08 $32.61 -$7.36 -$31.2 -$8.5 $30.3 -32.41% <-Total Growth 8 Net Income
Increase 49.45% -178.26% 52.85% -1087.78% 103.13% -94.01% 39667.07% -122.57% -323.51% 72.84% 457.86% EPS/CF Ratio should not be higher than 1.00
5 Yr Running Average -$1.1 -$1.7 -$3.2 -$4.0 -$12.7 -$11.3 -$11 -$3 -$3 -$0.9 -$2.9 $3.2 3.57% <-IRR #YR-> 8 Net Income
Operating Cash Flow -$0.6 -$1.1 -$2.6 -$5.4 $22.3 $76.5 $66.4 $9.5 $121.9 14.83% <-IRR #YR-> 5 Net Income
Investment Cash Flow $0.0 -$7.7 -$10.7 -$44.2 -$499.8 -$37.9 -$81.3 -$60.2 -$91.0 15.07% <-IRR #YR-> 8 5 Yr Running Average
Total Accruals -$4.9 $5.9 $5.5 $45.9 $433.7 -$37.3 $15.0 $83.3 -$38.3 -2.98% <-IRR #YR-> 5 5 Yr Running Average
Total Assets $0.4 $12.8 $58.5 $262.7 $1,262.4 $1,319.0 $1,409.3 $1,807.3 $2,096.9 Balance Sheet Assets
Accruals Ratio -1109.00% 46.20% 9.41% 17.47% 34.36% -2.82% 1.06% 4.61% -1.83% 1.06% <-Median-> 5 Ratio
EPS/CF Ratio (WC) 0.00 0.00 0.00 0.00 0.00 0.02 0.00 11.36 0.00 0.00 <-Median-> 9 EPS/CF Ratio
$5.6 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 -$7.4
$3.7 $0.0 $0.0 $0.0 $0.0 -$7.4
$1.1 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 -$3.4
$4.0 $0.0 $0.0 $0.0 $0.0 -$3.4
Change in Close 2.27% 246.67% 416.03% -39.01% -42.16% 35.56% 78.18% -41.84% 1.25% 0.00% 0.00% Count 9 Years of data
up/down up  down down down down Count 5 55.56%
Meet Prediction? Yes Yes Yes % right Count 3 60.00%
Financial Cash Flow $1.3 $11.9 -$10.7 $120.8 $452.5 -$52.8 $10.6 $113.5 -$25.9 C F Statement  Financial Cash Flow
Total Accruals -$6.2 -$6.0 $16.2 -$74.9 -$18.8 $15.6 $4.3 -$30.2 -$12.4 Accruals
Accruals Ratio -1410.34% -46.82% 27.68% -28.52% -1.49% 1.18% 0.31% -1.67% -0.59% -0.59% <-Median-> 5 Ratio
Cash $0.3 $2.2 $15.6 $86.9 $61.9 $48.9 $43.4 $131.7 $133.8 $134.0 Cash
Cash per Share $0.01 $0.03 $0.14 $0.53 $0.30 $0.21 $0.18 $0.53 $0.53 $0.53 $0.30 <-Median-> 5 Cash per Share
Percentage of Stock Price 1.48% 6.01% 8.68% 6.62% 6.03% 7.45% 4.67% 7.71% 13.20% 13.06% 7.45% <-Median-> 5 % of Stock Price
Notes:
July 20, 2026.  Last estimates were for 2025, 2026, 2027 of $1413M, $1547M, $1689M Revenue, $0.37, $0.39 2025/6 AEPS, 
$0.04, $0.09, $0.07 EPS, $63.9M, $82.50M, $95.1M FCF, $193.4M, $192.8M, $206.5M EBITDA, -$19M, $42.6M, $94.4M Net Income.
WELL Health Technologies company was established in February 2018 with the main offices based out of Vancouver, British Columbia, Canada. 
The company's founder and CEO is Hamed Shahbazi, previous CEO of TIO Networks, which was acquired by PayPal for $304M in 2017.
WELL Health Technologies has expanded through a number of mergers and acquisitions including the US-based CRH Medical Corp (2021), 
and ExecHealth (2021), Intrahealth Systems among others. A number of sources reported that Well Health Technologies is set to acquire 
Toronto-based MyHealth Centres, which will add 48 clinics to the company's network.
WELL Health Technologies trades on the Toronto Stock Exchange under the symbol ‘WELL’, on the OTCQX Exchange under the symbol ‘WHTCF’, 
on the Frankfurt Stock Exchange under the symbol ‘W7V’, on the Munich Stock Exchange under the symbol ‘W7U.MU’ and on the Stuttgart Stock Exchange under the symbol ‘CA94947L1022.SG’.
WELL went public in June 2017 through a reverse takeover transaction of Movarie Capital Ltd. on the TSX Venture Exchange. The Company was 
originally a yoga apparel company, a business which the company discontinued upon completion of its first acquisition of primary healthcare clinics 
in February 2018, followed by its first Electronic Medical Records acquisition in January 2019.
In November 2018, WELL Health Technologies Corp. completed the acquisition of thirteen primary healthcare clinics in British Columbia.
WELL Health Technologies Corp. did acquire MyHealth Centres in Toronto. The deal was finalized in July 2021, making 
WELL Health the largest outpatient integrated primary, specialty, and diagnostic healthcare provider in Canada. 
Sector:
Health Care.
What should this stock accomplish?
Would I buy this company and Why.
Why am I following this stock. 
Why I bought this stock.
I was interested in this stock when I heard it was to acquire Toronto based MyHealth Centers.
TSX stock investors can buy today is Well Health (TSX:WELL), a company that operates in the health-tech space. WELL stock has already returned over 4,000% to shareholders 
since its initial public offering in April 2016.  No Dividend.  Cantech Letter  
https://www.cantechletter.com/2025/07/well-health-technologies-has-an-increasingly-attractive-growth-profile-raymond-james-says/
Note:
Dividends
Dividends are not currently paid. 
Misson Statement or closes thing I can find.
What I am looking for is a statement that the company wants to do well by their customers, employees, and community and and thereby earn shareholders a reasonable return.
For customers 
For employees 
For community 
For investors 
How they make their money.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company.
Shares; '%, Value $M From Years Div. Gth Tot Ret Cap Gain Div. check Shares %, Val $M Shares %, Val $M Shares %, Val $M  
Date 2019 5 0.00% 34.47% 34.47% 0.00% 34.47% 2024 Jul 2025 Jul  2026
See below to Chairman 2017 7 0.00% 48.05% 48.05% 0.00% 48.05% 0.000 0.00% 0.000 0.00%
CEO - Shares - Amount $0.000 $0.000
Options - percentage From Years Div. Gth Tot Ret Cap Gain Div. check 0.000 0.00% 0.000 0.00%
Options - amount 2020 5 0.00% -13.10% -13.10% 0.00% -13.10% $0.000 $0.000
Reuters Options Value 2017 8 0.00% 31.73% 31.73% 0.00% 31.73% 0.000 $0
Fong, Eva 1.705 0.68% 1.965 0.77% 2.039 0.80%
CFO - Shares - Amount $11.699 $7.842 $8.239
Options - percentage 0.411 0.16% 0.153 0.06% 0.137 0.05%
Options - amount $2.818 $0.609 $0.555
Ericksen, Chris 0.000 0.00% 0.000 0.00% 0.000 0.00% Not found
Officer - Shares - Amount $0.000 $0.000 $0.000
Options - percentage 0.000 0.00% 0.000 0.00% 0.000 0.00%
Options - amount $0.000 $0.000 $0.000
Javidan, Amir 1.985 0.80% 2.057 0.81% 2.107 0.83%
Officer - Shares - Amount $13.620 $8.208 $8.513
Options - percentage 0.322 0.13% 0.153 0.06% 0.072 0.03%
Options - amount $2.209 $0.609 $0.291
Grimaldi, Loreto 0.000 0.00%
Officer - Shares - Amount $0.000
Options - percentage 0.214 0.08%
Options - amount $0.863
Lau, Sybil E. Jen 0.504 0.20% 0.548 0.22% 0.603 0.24%
Director - Shares - Amount $3.454 $2.188 $2.436
Options - percentage 0.145 0.06% 0.100 0.04% 0.172 0.07%
Options - amount $0.993 $0.399 $0.696
Cawkell, Kenneth Anthony 0.457 0.18% 0.479 0.19% 0.497 0.20%
Director - Shares - Amount $3.138 $1.910 $2.007
Options - percentage 0.053 0.02% 0.004 0.00% 0.050 0.02%
Options - amount $0.363 $0.015 $0.201
Shahbazi, Hamed 15.351 6.16% 15.355 6.05% 16.355 6.44%
Chairman & CEO - Shares - Amt $105.307 $61.265 $66.072
Options - percentage 0.894 0.36% 0.894 0.35% 2.639 1.04%
Options - amount $6.132 $3.567 $10.662
Increase in O/S Shares 5.150 2.18% 5.742 2.36% 3.111 1.23% Average
Due to Stock Options $19.827 $39.392 $12.414
Book Value $24.046 $27.701 $13.727
Insider Buying -$0.088 -$0.015 $0.000
Insider Selling $0.208 $0.000 $0.190
Net Insider Selling $0.120 -$0.015 $0.190
Net Selling % of Market Cap 0.01% 0.00% 0.02%
Directors 6 6
Women 2 33% 2 33%
Minorities 2 33% 2 33%
Institutions/Holdings 20 5.00% 20 4.62%
Total Shares Held 12.660 4.98% 11.789 4.64%
Increase/Decrease 3 Mths 0.694 5.80% 0.694 6.26%
Starting No. of Shares 11.966 11.094
FIX
My Stock